Reassessing the importance of long‐acting contraception

[1]  W. H. Pearse,et al.  American College of Obstetricians and Gynecologists , 2018, Definitions.

[2]  J. Peipert,et al.  From research to practice: dissemination of the Contraceptive CHOICE Project , 2017, Translational behavioral medicine.

[3]  Pai-Lien Chen,et al.  Long‐acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short‐acting methods: a randomized patient preference trial , 2017, American journal of obstetrics and gynecology.

[4]  Rachel K. Jones,et al.  Abortion Incidence and Service Availability In the United States, 2014 , 2017, Perspectives on sexual and reproductive health.

[5]  K. Curtis,et al.  U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[6]  L. Finer,et al.  Declines in Unintended Pregnancy in the United States, 2008–2011 , 2016 .

[7]  L. Finer,et al.  Declines in Unintended Pregnancy in the United States, 2008-2011. , 2016, The New England journal of medicine.

[8]  Adam Thomas,et al.  The intensive and extensive margins of contraceptive use: comparing the effects of method choice and method initiation. , 2016, Contraception.

[9]  Diana Foster,et al.  Projections and opinions from 100 experts in long-acting reversible contraception. , 2015, Contraception.

[10]  L. Finer,et al.  Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009–2012 , 2015, Obstetrics and gynecology.

[11]  C. Rocca,et al.  Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial , 2015, The Lancet.

[12]  C. Dehlendorf,et al.  Performance measures for contraceptive care: what are we actually trying to measure? , 2015, Contraception.

[13]  J. Trussell,et al.  Achieving cost-neutrality with long-acting reversible contraceptive methods. , 2015, Contraception.

[14]  J. Peipert,et al.  Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. , 2015, American journal of obstetrics and gynecology.

[15]  J. Peipert,et al.  The Contraceptive CHOICE Project Round Up: What We Did and What We Learned , 2014, Clinical obstetrics and gynecology.

[16]  J. Peipert,et al.  Provision of no-cost, long-acting contraception and teenage pregnancy. , 2014, The New England journal of medicine.

[17]  J. Higgins,et al.  Pull and pray or extra protection? Contraceptive strategies involving withdrawal among US adult women. , 2014, Contraception.

[18]  L. Fuentes,et al.  Women or LARC first? Reproductive autonomy and the promotion of long-acting reversible contraceptive methods. , 2014, Perspectives on sexual and reproductive health.

[19]  S. Ricketts,et al.  Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women. , 2014, Perspectives on sexual and reproductive health.

[20]  J. Higgins.  ARHP Commentary — Thinking (Re)Productively Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach ☆,☆☆ , 2014 .

[21]  J. Peipert,et al.  Medical contraindications in women seeking combined hormonal contraception. , 2014, American journal of obstetrics and gynecology.

[22]  Rachel K. Jones,et al.  Abortion incidence and service availability in the United States, 2011. , 2014, Perspectives on sexual and reproductive health.

[23]  R. Gold,et al.  Moving forward: Family planning in the era of health reform. , 2014 .

[24]  J. Peipert,et al.  Twenty-Four–Month Continuation of Reversible Contraception , 2013, Obstetrics and gynecology.

[25]  J. Peipert,et al.  Weight change at 12 months in users of three progestin-only contraceptive methods. , 2013, Contraception.

[26]  J. Peipert,et al.  Sexually Transmitted Infection Prevalence in a Population Seeking No-Cost Contraception , 2013, Sexually transmitted diseases.

[27]  G. Secura.  Long-acting reversible contraception: a practical solution to reduce unintended pregnancy. , 2013, Minerva ginecologica.

[28]  D. Paton,et al.  Preventing unintended pregnancies by providing no-cost contraception. , 2013, Obstetrics and gynecology.

[29]  Boonstra Hd.  Leveling the playing field: The promise of long-acting reversible contraceptives for adolescents. , 2013 .

[30]  J. Peipert,et al.  Preventing Unintended Pregnancies by Providing No-Cost Contraception , 2012, Obstetrics and gynecology.

[31]  J. Peipert,et al.  Continuation of Reversible Contraception in Teenagers and Young Women , 2012, Obstetrics and gynecology.

[32]  L. Finer,et al.  Changes in use of long-acting contraceptive methods in the United States, 2007-2009. , 2012, Fertility and sterility.

[33]  J. Peipert,et al.  Effectiveness of long-acting reversible contraception. , 2012, The New England journal of medicine.

[34]  Adam Thomas,et al.  Unintended pregnancy and taxpayer spending. , 2011, Perspectives on sexual and reproductive health.

[35]  J. Peipert,et al.  Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data. , 2011, Contraception.

[36]  J. Peipert,et al.  Continuation and Satisfaction of Reversible Contraception , 2011, Obstetrics and gynecology.

[37]  P. Blumenthal,et al.  Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. , 2011, Human reproduction update.

[38]  J. Higgins,et al.  Better than nothing or savvy risk-reduction practice? The importance of withdrawal. , 2009, Contraception.

[39]  E. Schwarz,et al.  Unintended pregnancy and associated maternal preconception, prenatal and postpartum behaviors. , 2009, Contraception.

[40]  Susheela Singh,et al.  Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth. , 2008, Contraception.

[41]  Denise V. D’Angelo,et al.  Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. , 2007, Morbidity and mortality weekly report. Surveillance summaries.

[42]  J. Manlove,et al.  The Consequences of Unintended Childbearing: A White Paper. , 2007 .

[43]  I. Sinai,et al.  Fertility awareness-based methods of family planning: predictors of correct use. , 2006, International family planning perspectives.

[44]  H. Leridon.  Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. , 2004, Human reproduction.

[45]  J. Darroch,et al.  Perspectives on Sexual and Reproductive Health Data Collection Contraceptive Use among U.s. Women Having Abortions in 2000–2001 , 2022 .

[46]  D. Dunson,et al.  Changes with age in the level and duration of fertility in the menstrual cycle. , 2002, Human reproduction.

[47]  Susheela Singh,et al.  Contraceptive failure in the first two years of use: differences across socioeconomic subgroups. , 2001, Family planning perspectives.

[48]  G. Zimmermann,et al.  3 Years of MOS in Orbit: What We Did and What We Learned , 1999 .

[49]  R. Winston,et al.  One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age. , 1998, Fertility and sterility.

[50]  Royston Jp,et al.  Basal body temperature, ovulation and the risk of conception, with special reference to the lifetimes of sperm and egg. , 1982, Biometrics.

[51]  J P Royston,et al.  Basal body temperature, ovulation and the risk of conception, with special reference to the lifetimes of sperm and egg. , 1982, Biometrics.

[52]  M. Potts,et al.  Textbook of Contraceptive Practice , 1969 .